Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Arcadia Biosciences, Inc. (RKDA) had Weighted-Average Shares Outstanding (Diluted) of 1.37M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$1.20M |
|
$2.60M |
|
$0.68M |
|
$0.52M |
|
$0.67M |
|
$0.53M |
|
$2.07M |
|
$2.60M |
|
$2.60M |
|
$2.60M |
|
$2.60M |
|
$2.60M |
|
$2.60M |
|
$0.53M |
|
$0.58M |
|
1.37M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.37M |
$1.90 |
|
$1.90 |
|
| Balance Sheet Financials | |
$8.85M |
|
$0.03M |
|
$4.14M |
|
$12.99M |
|
$2.22M |
|
-- |
|
$1.87M |
|
$4.08M |
|
$8.90M |
|
$8.87M |
|
$8.90M |
|
1.37M |
|
| Cash Flow Statement Financials | |
$-1.59M |
|
$0.50M |
|
$0.01M |
|
$4.24M |
|
$3.16M |
|
$-1.08M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
43.17% |
|
44.17% |
|
44.17% |
|
-- |
|
216.58% |
|
216.58% |
|
$-1.59M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.53 |
|
0.74 |
|
121.12 |
|
29.19% |
|
29.31% |
|
20.01% |
|
29.19% |
|
$6.51 |
|
$-1.16 |
|
$-1.16 |
|